GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » WDB coco Co Ltd (TSE:7079) » Definitions » GF Score

WDB coco Co (TSE:7079) GF Score : 76/100 (As of May. 16, 2024)


View and export this data going back to 2019. Start your Free Trial

What is WDB coco Co GF Score?

WDB coco Co has the GF Score of 76, which implies that the company is Likely to have average performance.

The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.

GF Score takes following five key aspects into consideration:

1. Financial Strength : 10/10
2. Profitability Rank : 8/10
3. Growth Rank : 8/10
4. GF Value Rank : 2/10
5. Momentum Rank : 2/10

Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.

Based on research and backtesting result, GuruFocus believes WDB coco Co is Likely to have average performance.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.


Competitive Comparison of WDB coco Co's GF Score

For the Health Information Services subindustry, WDB coco Co's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


WDB coco Co's GF Score Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, WDB coco Co's GF Score distribution charts can be found below:

* The bar in red indicates where WDB coco Co's GF Score falls into.



WDB coco Co  (TSE:7079) GF Score Explanation

Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:

GF Score Performance Potential and All-in-One Screener Examples (1)
91 - 100Highest outperformance potential
81 - 90Good outperformance potential
71 - 80Likely to have average performance
51 - 70Poor future performance potential
0 - 50Worst future performance potential, or not enough data

(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.


WDB coco Co GF Score Related Terms

Thank you for viewing the detailed overview of WDB coco Co's GF Score provided by GuruFocus.com. Please click on the following links to see related term pages.


WDB coco Co (TSE:7079) Business Description

Traded in Other Exchanges
N/A
Address
1-8-11 Harumi, Chuo-ku, Triton Square Y 27th Floor, Tokyo, JPN, 104-6127
WDB coco Co Ltd is a provider of safety information management for the development of pharmaceuticals and medical devices. Its services include business related to safety information management, preparation of materials related to regulatory application, QC related work, PMS facility contract support related work, clinical research support / monitoring, and temporary staffing. The company provides Contract Research Organization services for all new drug developments such as monitoring, safety information, data management and statistical analysis. It provides support for the development of generic drugs such as bioequivalence studies and biosimilars, clinical research and physician-led clinical trials.

WDB coco Co (TSE:7079) Headlines

No Headlines